Home/Cairn Biosciences/Mary Ludlam, PhD
ML

Mary Ludlam, PhD

Founder & CEO

Cairn Biosciences

Therapeutic Areas

Cairn Biosciences Pipeline

DrugIndicationPhase
Undisclosed Oncology Program(s)Cancer (focus on overcoming acquired resistance to targeted therapies)Preclinical